BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2468811)

  • 21. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma.
    van Vreeswijk H; Ruiter DJ; Bröcker EB; Welvaart K; Ferrone S
    J Invest Dermatol; 1988 May; 90(5):755-60. PubMed ID: 3283252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is the significance of HLA-DR antigen expression in the extraglomerular mesangium in glomerulonephritis?
    Gluhovschi C; Gluhovschi G; Potencz E; Lazar E; Petrica L; Bozdog G; Gadalean F; Bob F; Cioca D; Velciov S
    Hum Immunol; 2012 Nov; 73(11):1098-101. PubMed ID: 22890012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of MHC class II antigens (HLA DR, DP and DQ) by keratinocytes in oral lichen planus.
    Farthing PM; Cruchley AT
    J Oral Pathol Med; 1989 May; 18(5):305-9. PubMed ID: 2475620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class II (HLA-DR, HLA-DP, and HLA-DQ) antigens on colonic epithelia in ulcerative colitis: a comparison between uneventful and intractable cases.
    Horie Y; Chiba M; Iizuka M; Masamune O
    Tohoku J Exp Med; 1991 Oct; 165(2):87-97. PubMed ID: 1812596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues.
    Temponi M; Kekish U; Hamby CV; Nielsen H; Marboe CC; Ferrone S
    J Immunol Methods; 1993 May; 161(2):239-56. PubMed ID: 8505553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA class II expression in normal and inflamed conjunctiva.
    Lee SJ; Rice BA; Foster CS
    Reg Immunol; 1990-1991; 3(4):177-85. PubMed ID: 2129602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of HLA class II determinants by normal and chronic myeloid leukemia progenitors.
    Piacibello W; Aglietta M; Stacchini A; Spinelli P; Salvetti L; Kerim S; Malavasi F; Infelise V; Resegotti L; Gavosto F
    Leuk Res; 1987; 11(3):285-90. PubMed ID: 3470577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of class II MHC gene products by fallopian tube epithelium in pregnancy and throughout the menstrual cycle.
    Bulmer JN; Earl U
    Immunology; 1987 Jun; 61(2):207-13. PubMed ID: 3298023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens.
    Horejsí V; Nĕmec M; Angelisová P; Kristofová H; Gorga JC; Hilgert I
    Tissue Antigens; 1986 Nov; 28(5):288-97. PubMed ID: 2435017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increases in HLA-DQ, DP, DR, and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosing alveolitis.
    Haslam PL; Parker DJ; Townsend PJ
    Chest; 1990 Mar; 97(3):651-61. PubMed ID: 2306967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of HLA-DR, HLA-DP, and HLA-DQ antigenic determinants of the major histocompatibility complex in human endometrium.
    Tabibzadeh SS; Satyaswaroop PG
    Am J Reprod Immunol Microbiol; 1988 Dec; 18(4):124-30. PubMed ID: 3149871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma.
    Liversidge JM; Sewell HF; Forrester JV
    Clin Exp Immunol; 1988 Sep; 73(3):489-94. PubMed ID: 3145163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of glomerular and interstitial mononuclear leukocytes with different forms of glomerulonephritis.
    Markovic-Lipkovski J; Müller CA; Risler T; Bohle A; Müller GA
    Nephrol Dial Transplant; 1990; 5(1):10-7. PubMed ID: 2109281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium.
    Muczynski KA; Cotner T; Anderson SK
    Kidney Int; 2001 Feb; 59(2):488-97. PubMed ID: 11168931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
    Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The distribution and differential expression of MHC class II antigens (HLA-DR, DP, and DQ) in human fetal adrenal, pancreas, thyroid, and gut.
    Oliver AM; Sewell HF; Abramovich DR; Thomson AW
    Transplant Proc; 1989 Feb; 21(1 Pt 1):651-2. PubMed ID: 2495628
    [No Abstract]   [Full Text] [Related]  

  • 39. Reduction in HLA-DR, HLA-DQ and HLA-DP expression by Leu-M3+ cells from the peripheral blood of patients with thermal injury.
    Gibbons RA; Martinez OM; Lim RC; Horn JK; Garovoy MR
    Clin Exp Immunol; 1989 Mar; 75(3):371-5. PubMed ID: 2495202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification with the monoclonal antibody 26.163 of a determinant shared by the beta chains of the gene products of the HLA-DR, DQ, and DP loci.
    Igarashi M; Gebhard DH; Chen YX; Safai B; Evans RL; Ferrone S
    Hum Immunol; 1986 Aug; 16(4):347-55. PubMed ID: 2428781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.